New hope for prostate cancer patients in Early-Stage drug trial
NCT ID NCT05367440
Summary
This early-stage clinical trial is testing whether adding an experimental drug called AZD5305 to standard hormone therapies is safe and effective for men with metastatic prostate cancer. The study involves about 174 patients and will measure side effects, how the drugs work in the body, and early signs of whether the combination helps control the cancer. Treatment continues until the cancer progresses or side effects become too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
Detroit, Michigan, 48202, United States
-
Research Site
Syracuse, New York, 13210, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Houston, Texas, 77094, United States
-
Research Site
Camperdown, 2050, Australia
-
Research Site
Darlinghurst, 2010, Australia
-
Research Site
East Melbourne, 3002, Australia
-
Research Site
Heidelberg, 3084, Australia
-
Research Site
Melbourne, 3004, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Candiolo, 10060, Italy
-
Research Site
Milan, 20133, Italy
-
Research Site
Orbassano, 10043, Italy
-
Research Site
Padua, 35128, Italy
-
Research Site
Cambridge, CB2 0QQ, United Kingdom
-
Research Site
Glasgow, G12 0YN, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Plymouth, PL6 8DH, United Kingdom
Conditions
Explore the condition pages connected to this study.